Understanding protein sugar addition problems in rare genetic disorders
Official title: Identifying understudied protein-related glycoproteome disruption in Congenital Disorders of Glycosylation
Funded at Children's Hosp of Philadelphia · NIH-10725869 · Data updated 2026-11-12
This study is looking at rare genetic conditions called congenital disorders of glycosylation (CDG) to find out how certain proteins are affected by genetic changes, with the hope of discovering new ways to help improve the health of people living with these disorders.
Quick facts
| Grant type | R03 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Children's Hosp of Philadelphia NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project start | August 1, 2023 |
| Project end | July 31, 2025 |
| Funding year | 2023 |
| Award (this year) | $188,000 |
| NIH project number | 1R03TR004626-01 |
| Project ID | NIH-10725869 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals diagnosed with congenital disorders of glycosylation, particularly those with known genetic mutations affecting glycosylation processes.
✕Less likely to help
Patients with other genetic disorders not related to glycosylation may not benefit from this research.
What this research studies
This research investigates congenital disorders of glycosylation (CDG), which are rare genetic diseases that disrupt the process of adding sugar structures to proteins. By analyzing patient samples using advanced mass spectrometry techniques, the study aims to identify specific proteins that are affected by genetic mutations and contribute to the symptoms of CDG. The goal is to uncover the underlying mechanisms of these disorders and explore potential new treatment strategies that could improve patient outcomes.
Why it matters
Potential benefit: If successful, this research could lead to new insights and treatment options for patients suffering from congenital disorders of glycosylation.
How similar studies have gone: While the approach of studying glycoproteomic disruptions in CDG is relatively novel, similar research in other genetic disorders has shown promising results in understanding disease mechanisms and developing targeted therapies.
Where this research is happening
-
Children's Hosp of Philadelphia
Philadelphia, United States Active
Researchers
- Principal investigator: Edmondson, Andrew Charles — Children's Hosp of Philadelphia
- Study coordinator: Edmondson, Andrew Charles
Related research
Other NIH-funded projects on the same topics.
-
Emotional and biobehavioral links in parent-infant closeness
A program to understand how parent and baby feel and react to each other in early life, with the goal of guiding better child social and emotional development.
-
Leukodystrophy Clinical Careers and Mentorship Network
A program to train, mentor, and support clinicians and researchers to advance care for people with leukodystrophies.
-
Role of ATP1A3 mutations in sudden death related to epilepsy
Aims to understand how ATP1A3 gene changes may lead to sudden death in kids with epilepsy and is exploring new ways to prevent it.
-
Kids First Data Resource Center: cloud-enabled data sharing for childhood cancer research
A data resource project that makes pediatric cancer data and analyses more accessible to researchers, with the goal of advancing understanding and care for children with cancer.
-
PROMISE: A Network for Real-World Evidence in Rare Pediatric Cancers
A network will collect and harmonize pediatric cancer patient records from multiple centers to create high-quality real-world data that can support quicker, regulatory-ready insights when randomized trials aren’t feasible.
-
Data Hub Core for Down syndrome research
A data hub project is building a big, interoperable platform to securely share and analyze information from people with Down syndrome and related conditions.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.